CLINICAL_TRIALS
trial_result
· 2019-08-12
Clinical Trial Update: Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging [Phase 1]
Summary
Phase 1 trial update for single doses of GSK3008348 in idiopathic pulmonary fibrosis with PET imaging; study terminated with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: TERMINATED | Results posted: 2019-08-12